BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22840058)

  • 1. Preparation of the β-cyclodextrin-vitamin C (β-CD-Vc) inclusion complex under high hydrostatic pressure (HHP).
    Hu X; Wei B; Li H; Wu C; Bai Y; Xu X; Jin Z; Tian Y
    Carbohydr Polym; 2012 Oct; 90(2):1193-6. PubMed ID: 22840058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY; Hsu CH; Sheu MT
    J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
    El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and thermal stability of β-cyclodextrin/soybean lecithin inclusion complex.
    Wang X; Luo Z; Xiao Z
    Carbohydr Polym; 2014 Jan; 101():1027-32. PubMed ID: 24299871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L; Jing J; Chen G; Miao Y; Wei P
    J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
    Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
    Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C; Longhi M
    J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding.
    Aigner Z; Berkesi O; Farkas G; Szabó-Révész P
    J Pharm Biomed Anal; 2012 Jan; 57():62-7. PubMed ID: 21920691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
    Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
    J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral characteristics of tramadol in different solvents and beta-cyclodextrin.
    Anton Smith A; Manavalan R; Kannan K; Rajendiran N
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(2):469-77. PubMed ID: 19665424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.
    Lu Y; Zhang T; Tao J; Ji G; Wang S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and spectroscopy studies of the inclusion complex of 3-amino-5-methyl pyrazole with beta-cyclodextrin.
    Louiz S; Labiadh H; Abderrahim R
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():276-82. PubMed ID: 25022499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
    Yuexian F; Junfen L; Chuan D
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.